Chen Chen, MD
Dermatology · San Carlos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 10
- 2 carriers
- Office
- 1
- Since medical school
- 10 years
- Harvard Medical School, 2016
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plans that list them
10 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chen’s office at (415) 600-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
10 of 10 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A152433 · Current
Licensed to practise in California · since 2017 · expires 2027-10-31 · Harvard Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Dermatology - Dermatology
Original Medicare doctor bills
$152,597
Medicare paid this office $152,597 for 670 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 385 | $37,538 | $75 |
| Destruction of skin growth, 1-14 growths | 250 | $31,914 | $107 |
| Biopsy of related skin growth, first growth | 146 | $13,800 | $85 |
| Return visit (30+ min) | 108 | $11,752 | $97 |
| New patient visit (30+ min) | 124 | $10,341 | $83 |
See all 15 services
| Short return visit (20+ min) | 385 | $37,538 | $75 |
| Destruction of skin growth, 1-14 growths | 250 | $31,914 | $107 |
| Biopsy of related skin growth, first growth | 146 | $13,800 | $85 |
| Return visit (30+ min) | 108 | $11,752 | $97 |
| New patient visit (30+ min) | 124 | $10,341 | $83 |
| Destruction of precancer skin growth, 1 growth | 174 | $10,084 | $49 |
| New patient visit (45+ min) | 48 | $5,936 | $124 |
| Destruction of precancer skin growth, 2-14 growths | 138 | $4,534 | $7 |
| Punch biopsy, first skin growth | 28 | $3,250 | $116 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 12 | $3,250 | $271 |
| Biopsy of related skin growth, each additional growth | 38 | $2,852 | $52 |
| Short return visit | 59 | $2,838 | $46 |
| Injection into skin growth, 1-7 growths | 18 | $1,282 | $49 |
| New patient visit (15+ min) | 17 | $955 | $56 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 19 | $38 | None |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 18 | More than 73% of doctors who do this |
| Removal of skin lesions | 712 | More than 90% of doctors who do this |
| Removal or shaving of skin growth | 35 | More than 76% of doctors who do this |
| Skin biopsy | 328 | More than 92% of doctors who do this |
Procedures year by year
| Procedure | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 89 | 238 | 339 | 604 | 666 |
| Destruction of skin growth, 1-14 growths | 16 | 99 | 139 | 272 | 299 |
| Destruction of precancer skin growth, 1 growth | 20 | 90 | 101 | 215 | 207 |
| Biopsy of related skin growth, first growth | 19 | 57 | 39 | 136 | 162 |
| Punch biopsy, first skin growth | – | 17 | 27 | 32 | 28 |
| Biopsy of related skin growth, each additional growth | – | 17 | – | 30 | 55 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
670 Original Medicare patients in 2024. Average age 75 · Under 65 2% · 85 and older 12% · Women 57% · Also on Medicaid 6% · Health risk score 0.78. At or below the middle of the specialty; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 57% · Diabetes 17% · Coronary heart disease 17% · Chronic kidney disease 14% · Atrial fibrillation 13% · Cancer 12% · Depression 10% · Heart failure 7% · COPD 5% · Stroke 4% · Dementia 2%.
The office billed $569,523, Medicare allowed $218,525 and paid $152,597; for 2,599 services of 41 kinds; $38 of it was for drugs given in the office and $152,560 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 670 | 2,599 | 75 | 0.78 | $569,523 | $152,597 |
| 2023 | 551 | 2,346 | 74 | 0.80 | $534,792 | $154,038 |
| 2022 | 269 | 1,339 | 75 | 0.87 | $252,413 | $76,143 |
| 2021 | 275 | 1,034 | 74 | 0.84 | $227,393 | $66,610 |
| 2020 | 76 | 261 | 74 | 0.73 | $46,211 | $13,586 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 14 services
| Destruction of skin growth, 1-14 growths | 211 | $29,869 | $110 |
| Short return visit (20+ min) | 279 | $29,775 | $77 |
| Return visit (30+ min) | 157 | $20,714 | $103 |
| New patient visit (30+ min) | 141 | $12,273 | $87 |
| Biopsy of related skin growth, first growth | 113 | $11,980 | $88 |
| Destruction of precancer skin growth, 1 growth | 169 | $10,136 | $47 |
| New patient visit (45+ min) | 75 | $9,597 | $128 |
| Destruction of precancer skin growth, 2-14 growths | 134 | $4,233 | $7 |
| Punch biopsy, first skin growth | 31 | $3,958 | $124 |
| Destruction of skin growth, 15 or more growths | 12 | $1,866 | $124 |
| Biopsy of related skin growth, each additional growth | 20 | $1,572 | $52 |
| Injection into skin growth, 1-7 growths | 13 | $1,136 | $52 |
| Short return visit | 18 | $947 | $53 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 13 | $20 | None |
2022: 9 services
| Destruction of skin growth, 1-14 growths | 112 | $15,178 | $109 |
| Short return visit (20+ min) | 145 | $14,166 | $77 |
| Return visit (30+ min) | 60 | $8,157 | $112 |
| New patient visit (30+ min) | 68 | $6,057 | $89 |
| Destruction of precancer skin growth, 1 growth | 82 | $4,792 | $47 |
| New patient visit (45+ min) | 28 | $3,652 | $130 |
| Punch biopsy, first skin growth | 26 | $3,382 | $125 |
| Biopsy of related skin growth, first growth | 35 | $3,337 | $86 |
| Destruction of precancer skin growth, 2-14 growths | 68 | $2,372 | $7 |
2021: 11 services
| Destruction of skin growth, 1-14 growths | 82 | $11,066 | $112 |
| Short return visit (20+ min) | 96 | $9,333 | $80 |
| New patient visit (30+ min) | 95 | $8,739 | $92 |
| Return visit (30+ min) | 49 | $5,569 | $99 |
| Biopsy of related skin growth, first growth | 54 | $5,399 | $95 |
| New patient visit (45+ min) | 47 | $5,159 | $110 |
| Destruction of precancer skin growth, 1 growth | 81 | $4,032 | $45 |
| Punch biopsy, first skin growth | 16 | $2,256 | $133 |
| Destruction of precancer skin growth, 2-14 growths | 62 | $1,609 | $7 |
| Biopsy of related skin growth, each additional growth | 13 | $925 | $54 |
| Short return visit | 11 | $592 | $46 |
2020: 7 services
| Short return visit (20+ min) | 35 | $2,482 | $64 |
| New patient visit (30+ min) | 25 | $2,384 | $95 |
| Destruction of skin growth, 1-14 growths | 15 | $1,664 | $104 |
| Biopsy of related skin growth, first growth | 18 | $1,650 | $87 |
| New patient visit (15+ min) | 14 | $962 | $69 |
| Destruction of precancer skin growth, 1 growth | 19 | $904 | $45 |
| Destruction of precancer skin growth, 2-14 growths | 13 | $545 | $6 |
Medicaid work
$36 in 2019
Medicaid paid $36 for 67 billed services this clinician did in 2019, up to 33 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 53 | $36 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 14 | $0 |
| 2019 | 67 | 2 | 33 | $36 |
| 2018 | 57 | 1 | 22 | $24 |
See the largest Medicaid services in earlier years
2018
| Short return visit (20+ min) | 57 | $24 |
Drugs they prescribed that Part D paid
$195,482
Pharmacies billed $195,482 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 794) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
721 generic and 73 brand-name prescriptions · $195,482 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Dupixent | 15 | $56,076 | $3,738 |
| Opzelura | 14 | $27,304 | $1,950 |
| Tacrolimus | 81 | $5,561 | $69 |
| Clobetasol Propionate | 59 | $2,179 | $37 |
| Fluocinonide | 54 | $1,294 | $24 |
See all 13 drugs
| Dupixent | 15 | $56,076 | $3,738 |
| Opzelura | 14 | $27,304 | $1,950 |
| Tacrolimus | 81 | $5,561 | $69 |
| Clobetasol Propionate | 59 | $2,179 | $37 |
| Fluocinonide | 54 | $1,294 | $24 |
| Fluorouracil | 20 | $954 | $48 |
| Desonide | 27 | $826 | $31 |
| Ketoconazole | 65 | $725 | $11 |
| Triamcinolone Acetonide | 133 | $526 | $4 |
| Hydrocortisone | 136 | $519 | $4 |
| Clindamycin Phosphate | 22 | $506 | $23 |
| Ciclopirox | 17 | $295 | $17 |
| Mupirocin | 22 | $125 | $6 |
Year by year
| 2024 | 794 | 325 | 0% (0) | 9% | $195,482 |
| 2023 | 678 | 281 | 0% (0) | 9% | $297,076 |
| 2022 | 374 | 149 | 0% (0) | 13% | $170,603 |
| 2021 | 337 | 151 | 0% (0) | 5% | $39,890 |
| 2020 | 79 | 39 | 0% (0) | None | $8,597 |
| 2019 | 22 | 11 | 0% (0) | 0% | $1,229 |
| 2018 | 13 | None | None | None | $867 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 13 drugs
| Dupixent | 26 | $102,150 | $3,929 |
| Tacrolimus | 35 | $4,340 | $124 |
| Fluorouracil | 30 | $2,741 | $91 |
| Fluocinonide | 38 | $2,029 | $53 |
| Clobetasol Propionate | 55 | $1,613 | $29 |
| Metronidazole | 12 | $1,165 | $97 |
| Ketoconazole | 60 | $1,007 | $17 |
| Triamcinolone Acetonide | 140 | $1,007 | $7 |
| Clindamycin Phosphate | 14 | $679 | $48 |
| Desonide | 15 | $548 | $37 |
| Hydrocortisone | 105 | $506 | $5 |
| Mupirocin | 35 | $434 | $12 |
| Valacyclovir | 11 | $129 | $12 |
2022: 9 drugs
| Dupixent | 22 | $76,965 | $3,498 |
| Tacrolimus | 19 | $3,934 | $207 |
| Fluocinonide | 25 | $1,584 | $63 |
| Clobetasol Propionate | 15 | $1,217 | $81 |
| Clindamycin Phosphate | 14 | $989 | $71 |
| Ketoconazole | 36 | $733 | $20 |
| Triamcinolone Acetonide | 84 | $598 | $7 |
| Hydrocortisone | 63 | $318 | $5 |
| Mupirocin | 19 | $204 | $11 |
2021: 7 drugs
| Clobetasol Propionate | 20 | $1,239 | $62 |
| Fluocinonide | 21 | $1,106 | $53 |
| Ketoconazole | 44 | $1,089 | $25 |
| Desonide | 13 | $602 | $46 |
| Triamcinolone Acetonide | 71 | $564 | $8 |
| Hydrocortisone | 64 | $312 | $5 |
| Mupirocin | 25 | $232 | $9 |
2020: 2 drugs
| Triamcinolone Acetonide | 19 | $359 | $19 |
| Hydrocortisone | 16 | $81 | $5 |
Money from drug and device companies
$3,746 in 2025
| 2025 | 16 | 161 | None | $3,746 |
| 2024 | 14 | 68 | None | $1,448 |
| 2023 | 12 | 40 | None | $1,196 |
| 2022 | 6 | 11 | None | $264 |
| 2021 | 1 | 4 | None | $72 |
| 2020 | 1 | 3 | None | $73 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Incyte | Opzelura | $732 | 30 payments
|
| Galderma Laboratories L.P. | Nemluvio | $507 | 16 payments
|
| Lilly USA | Taltz | $469 | 17 payments
|
| Arcutis Biotherapeutics | Zoryve | $456 | 23 payments
|
| Regeneron Healthcare Solutions | Dupixent | $284 | 16 payments
|
| Janssen Biotech | Tremfya | $246 | 14 payments
|
See all 161 published payments
| Janssen Biotech | Meals · 2025-12-23 | Tremfya | $1 |
| Janssen Biotech | Meals · 2025-12-22 | Tremfya | $21 |
| Incyte | Meals · 2025-12-17 | Opzelura | $28 |
| Arcutis Biotherapeutics | Meals · 2025-12-16 | Zoryve | $19 |
| Novartis Pharmaceuticals | Meals · 2025-12-12 | Cosentyx | $29 |
| Ucb | Meals · 2025-12-12 | Bimzelx | $37 |
| Incyte | Meals · 2025-12-11 | Opzelura | $20 |
| LEO Pharma | Meals · 2025-12-11 | Adbry | $15 |
| LEO Pharma | Meals · 2025-12-11 | Adbry | $15 |
| Regeneron Healthcare Solutions | Meals · 2025-12-10 | Dupixent | $27 |
| Arcutis Biotherapeutics | Meals · 2025-12-09 | Zoryve | $27 |
| Janssen Biotech | Meals · 2025-12-06 | Tremfya | $20 |
| Galderma Laboratories L.P. | Meals · 2025-12-05 | Nemluvio | $15 |
| Novartis Pharmaceuticals | Meals · 2025-12-04 | Cosentyx | $24 |
| Organon | Meals · 2025-12-03 | Vtama | $32 |
| Genzyme | Meals · 2025-12-02 | Dupixent | $39 |
| Arcutis Biotherapeutics | Meals · 2025-12-02 | Zoryve | $20 |
| Incyte | Meals · 2025-11-27 | Opzelura | $29 |
| Amgen | Meals · 2025-11-25 | Otezla | $34 |
| Arcutis Biotherapeutics | Meals · 2025-11-20 | Zoryve | $8 |
| Arcutis Biotherapeutics | Meals · 2025-11-20 | Zoryve | $11 |
| Janssen Biotech | Meals · 2025-11-19 | Tremfya | $23 |
| Cipher Pharmaceuticals US | Meals · 2025-11-11 | Natroba | $15 |
| Genzyme | Meals · 2025-11-05 | Dupixent | $37 |
| Incyte | Meals · 2025-10-29 | Opzelura | $29 |
| Ucb | Meals · 2025-10-25 | Bimzelx | $29 |
| Genzyme | Meals · 2025-10-23 | Dupixent | $34 |
| Arcutis Biotherapeutics | Meals · 2025-10-23 | Zoryve | $19 |
| Galderma Laboratories L.P. | Meals · 2025-10-22 | Nemluvio | $33 |
| Incyte | Meals · 2025-10-21 | Opzelura | $25 |
| Incyte | Meals · 2025-10-17 | Opzelura | $28 |
| Lilly USA | Meals · 2025-10-16 | None | $74 |
| Regeneron Healthcare Solutions | Meals · 2025-10-16 | Dupixent | $27 |
| Galderma Laboratories L.P. | Meals · 2025-10-16 | Nemluvio | $15 |
| Galderma Laboratories L.P. | Meals · 2025-10-16 | Nemluvio | $7 |
| Arcutis Biotherapeutics | Meals · 2025-10-15 | Zoryve | $13 |
| Amgen | Meals · 2025-10-09 | Otezla | $7 |
| Amgen | Meals · 2025-10-09 | Otezla | $2 |
| Amgen | Meals · 2025-10-09 | Otezla | $10 |
| Galderma Laboratories L.P. | Meals · 2025-10-09 | Nemluvio | $36 |
| Galderma Laboratories L.P. | Meals · 2025-10-09 | Nemluvio | $0 |
| Incyte | Meals · 2025-10-08 | Opzelura | $24 |
| Genzyme | Meals · 2025-10-07 | Dupixent | $30 |
| Incyte | Meals · 2025-10-02 | Opzelura | $120 |
| Arcutis Biotherapeutics | Meals · 2025-10-01 | Zoryve | $25 |
| Regeneron Healthcare Solutions | Education · 2025-09-30 | Dupixent | $5 |
| Regeneron Healthcare Solutions | Meals · 2025-09-30 | Dupixent | $19 |
| Incyte | Meals · 2025-09-30 | Opzelura | $8 |
| Abbvie | Meals · 2025-09-27 | Skyrizi | $14 |
| Abbvie | Meals · 2025-09-24 | Rinvoq | $24 |
| Organon | Meals · 2025-09-24 | None | $25 |
| Lilly USA | Meals · 2025-09-23 | Taltz | $28 |
| Galderma Laboratories L.P. | Meals · 2025-09-23 | Nemluvio | $26 |
| Arcutis Biotherapeutics | Meals · 2025-09-23 | Zoryve | $30 |
| Ucb | Meals · 2025-09-18 | Bimzelx | $9 |
| Ucb | Meals · 2025-09-18 | Bimzelx | $16 |
| Incyte | Meals · 2025-09-17 | Opzelura | $21 |
| Incyte | Meals · 2025-09-17 | Opzelura | $29 |
| LEO Pharma | Meals · 2025-09-11 | Adbry | $21 |
| Lilly USA | Meals · 2025-09-10 | Ebglyss | $26 |
| Incyte | Meals · 2025-09-10 | Opzelura | $27 |
| Janssen Biotech | Meals · 2025-09-04 | Tremfya | $4 |
| Janssen Biotech | Meals · 2025-09-04 | Tremfya | $22 |
| Janssen Biotech | Meals · 2025-09-04 | Tremfya | $0 |
| Regeneron Healthcare Solutions | Meals · 2025-09-04 | Dupixent | $6 |
| Regeneron Healthcare Solutions | Meals · 2025-09-04 | Dupixent | $5 |
| Incyte | Meals · 2025-09-04 | Opzelura | $26 |
| Organon | Meals · 2025-08-29 | Vtama | $9 |
| Organon | Meals · 2025-08-29 | Vtama | $25 |
| Galderma Laboratories L.P. | Meals · 2025-08-28 | Nemluvio | $38 |
| Arcutis Biotherapeutics | Meals · 2025-08-28 | Zoryve | $6 |
| Janssen Biotech | Meals · 2025-08-27 | Tremfya | $16 |
| Lilly USA | Meals · 2025-08-27 | Taltz | $11 |
| Lilly USA | Meals · 2025-08-27 | Taltz | $11 |
| Incyte | Meals · 2025-08-27 | Opzelura | $25 |
| Genzyme | Meals · 2025-08-27 | Dupixent | $33 |
| Abbvie | Meals · 2025-08-21 | Skyrizi | $28 |
| Lilly USA | Meals · 2025-08-20 | Taltz | $24 |
| Regeneron Healthcare Solutions | Meals · 2025-08-20 | Dupixent | $25 |
| Janssen Biotech | Meals · 2025-08-13 | Tremfya | $32 |
| Incyte | Meals · 2025-08-13 | Opzelura | $20 |
| Lilly USA | Meals · 2025-08-07 | Taltz | $29 |
| Incyte | Meals · 2025-08-06 | Opzelura | $30 |
| Incyte | Meals · 2025-08-01 | Opzelura | $18 |
| Arcutis Biotherapeutics | Meals · 2025-08-01 | Zoryve | $19 |
| Genzyme | Meals · 2025-07-31 | Dupixent | $25 |
| Lilly USA | Meals · 2025-07-29 | Taltz | $29 |
| Organon | Meals · 2025-07-29 | Vtama | $18 |
| Janssen Biotech | Meals · 2025-07-24 | Tremfya | $2 |
| Janssen Biotech | Meals · 2025-07-23 | Tremfya | $26 |
| Regeneron Healthcare Solutions | Meals · 2025-07-23 | Dupixent | $26 |
| Incyte | Meals · 2025-07-15 | Opzelura | $29 |
| Amgen | Meals · 2025-07-14 | Otezla | $31 |
| Arcutis Biotherapeutics | Meals · 2025-07-14 | Zoryve | $7 |
| Regeneron Healthcare Solutions | Meals · 2025-07-11 | Dupixent | $20 |
| Incyte | Meals · 2025-07-03 | Opzelura | $17 |
| Organon | Meals · 2025-07-01 | Vtama | $23 |
| Regeneron Healthcare Solutions | Meals · 2025-06-28 | Dupixent | $10 |
| Galderma Laboratories L.P. | Meals · 2025-06-27 | Nemluvio | $39 |
| Arcutis Biotherapeutics | Meals · 2025-06-27 | Zoryve | $8 |
| Regeneron Healthcare Solutions | Meals · 2025-06-24 | Dupixent | $27 |
| Lilly USA | Meals · 2025-06-18 | Taltz | $29 |
| Arcutis Biotherapeutics | Meals · 2025-06-18 | Zoryve | $9 |
| Genzyme | Meals · 2025-06-17 | Dupixent | $42 |
| Janssen Biotech | Meals · 2025-06-12 | Tremfya | $32 |
| Arcutis Biotherapeutics | Meals · 2025-06-12 | Zoryve | $10 |
| Lilly USA | Meals · 2025-06-11 | Taltz | $30 |
| Incyte | Meals · 2025-06-05 | Opzelura | $21 |
| Amgen | Meals · 2025-05-30 | Otezla | $2 |
| Amgen | Meals · 2025-05-30 | Otezla | $30 |
| Incyte | Meals · 2025-05-29 | Opzelura | $4 |
| Galderma Laboratories L.P. | Meals · 2025-05-29 | Nemluvio | $34 |
| Incyte | Meals · 2025-05-28 | Opzelura | $7 |
| Incyte | Meals · 2025-05-28 | Opzelura | $7 |
| Regeneron Healthcare Solutions | Meals · 2025-05-27 | Dupixent | $21 |
| Arcutis Biotherapeutics | Meals · 2025-05-23 | Zoryve | $15 |
| Galderma Laboratories L.P. | Meals · 2025-05-22 | Nemluvio | $29 |
| Abbvie | Meals · 2025-05-21 | Rinvoq | $17 |
| Lilly USA | Meals · 2025-05-20 | Taltz | $4 |
| Lilly USA | Meals · 2025-05-18 | Taltz | $28 |
| Ucb | Meals · 2025-05-14 | Bimzelx | $33 |
| Abbvie | Meals · 2025-05-07 | Skyrizi | $27 |
| Incyte | Meals · 2025-05-07 | Opzelura | $13 |
| Amgen | Meals · 2025-05-07 | Otezla | $28 |
| Galderma Laboratories L.P. | Meals · 2025-05-07 | Nemluvio | $37 |
| Incyte | Meals · 2025-05-02 | Opzelura | $28 |
| Incyte | Meals · 2025-04-22 | Opzelura | $28 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-04-17 | Sotyktu | $28 |
| Amgen | Meals · 2025-04-16 | Otezla | $1 |
| Amgen | Meals · 2025-04-16 | Otezla | $20 |
| Galderma Laboratories L.P. | Meals · 2025-04-15 | Nemluvio | $32 |
| Incyte | Meals · 2025-04-10 | Opzelura | $15 |
| Lilly USA | Meals · 2025-04-09 | Taltz | $30 |
| Pfizer | Meals · 2025-04-08 | Cibinqo | $29 |
| Arcutis Biotherapeutics | Meals · 2025-03-28 | Zoryve | $23 |
| Arcutis Biotherapeutics | Meals · 2025-03-27 | Zoryve | $25 |
| Regeneron Healthcare Solutions | Education · 2025-03-20 | Dupixent | $7 |
| Janssen Biotech | Meals · 2025-03-19 | Tremfya | $26 |
| Galderma Laboratories L.P. | Meals · 2025-03-19 | Nemluvio | $122 |
| Lilly USA | Meals · 2025-03-18 | Ebglyss | $24 |
| Regeneron Healthcare Solutions | Meals · 2025-03-06 | Dupixent | $10 |
| Ucb | Meals · 2025-02-28 | Bimzelx | $22 |
| Organon | Meals · 2025-02-28 | Vtama | $17 |
| Arcutis Biotherapeutics | Meals · 2025-02-28 | Zoryve | $71 |
| Arcutis Biotherapeutics | Meals · 2025-02-26 | Zoryve | $23 |
| Galderma Laboratories L.P. | Meals · 2025-02-20 | Nemluvio | $19 |
| Lilly USA | Meals · 2025-02-17 | Taltz | $29 |
| Incyte | Meals · 2025-02-13 | Opzelura | $30 |
| Janssen Biotech | Meals · 2025-02-12 | Tremfya | $20 |
| Regeneron Healthcare Solutions | Meals · 2025-02-06 | Dupixent | $24 |
| Arcutis Biotherapeutics | Meals · 2025-01-30 | Zoryve | $29 |
| Galderma Laboratories L.P. | Meals · 2025-01-22 | Nemluvio | $26 |
| Amgen | Meals · 2025-01-21 | Otezla | $33 |
| Arcutis Biotherapeutics | Meals · 2025-01-21 | Zoryve | $17 |
| Lilly USA | Meals · 2025-01-16 | Taltz | $33 |
| Organon | Meals · 2025-01-15 | Vtama | $33 |
| Regeneron Healthcare Solutions | Meals · 2025-01-08 | Dupixent | $25 |
| Incyte | Meals · 2025-01-08 | Opzelura | $19 |
| Incyte | Meals · 2025-01-08 | Opzelura | $2 |
| Lilly USA | Meals · 2025-01-03 | Taltz | $31 |
| Arcutis Biotherapeutics | Meals · 2025-01-03 | Zoryve | $22 |
See earlier years (2024, 2023, 2022, 2021, 2020)
2024: $1,448
| Amgen | Otezla | $267 | 10 payments
|
| Janssen Biotech | Tremfya | $246 | 13 payments
|
| Regeneron Healthcare Solutions | Dupixent | $179 | 9 payments
|
| Incyte | Opzelura | $164 | 13 payments
|
| Arcutis Biotherapeutics | Zoryve | $136 | 7 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $86 | 3 payments
|
| Lilly USA | Taltz | $84 | 3 payments
|
| Ucb | Bimzelx | $62 | 2 payments
|
| Dermavant Sciences | Vtama | $56 | 2 payments
|
| Galderma Laboratories L.P. | None | $50 | 2 payments
|
| Novartis Pharmaceuticals | Xolair | $32 | 1 payment
|
| Sun Pharmaceutical Industries | Ilumya | $31 | 1 payment
|
| Abbvie | Skyrizi | $27 | 1 payment
|
| Pfizer | Cibinqo | $27 | 1 payment
|
2023: $1,196
| AbbVie | Skyrizi | $254 | 8 payments
|
| Janssen Biotech | Tremfya | $204 | 5 payments
|
| Regeneron Healthcare Solutions | Dupixent | $188 | 8 payments
|
| Incyte | Opzelura | $146 | 3 payments
|
| Amgen | Otezla | $133 | 6 payments
|
| LEO Pharma | Adbry | $84 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $56 | 2 payments
|
| Genzyme | Fabrazyme | $31 | 1 payment
|
| Arcutis Biotherapeutics | None | $30 | 1 payment
|
| Dermavant Sciences | Vtama | $29 | 1 payment
|
| Sun Pharmaceutical Industries | Winlevi | $26 | 1 payment
|
| Pfizer | Eucrisa | $17 | 1 payment
|
2022: $264
| LEO Pharma | Adbry | $67 | 3 payments
|
| Regeneron Healthcare Solutions | Dupixent | $56 | 2 payments
|
| Incyte | Opzelura | $49 | 2 payments
|
| Abbvie | Rinvoq | $47 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $24 | 1 payment
|
| Genzyme | Fabrazyme | $21 | 1 payment
|
2021: $72
| AbbVie | Skyrizi | $72 | 4 payments
|
2020: $73
| AbbVie | Skyrizi | $73 | 3 payments
|
Professional record
- NPI
- 1114380631
- Licence
- CA A152433California A152433: Current · expires 2027-10-31
- Trained
- Harvard Medical School, 2016 · 10 years ago
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207N00000X (207N00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2016-04-01
- NPI last updated
- 2020-08-13
- NPI record certified
- 2020-08-13
This is when the NPI record was last certified, not a medical board exam.